FATE logo

Fate Therapeutics (FATE) Total Liabilities

Annual Total Liabilities

$137.80 M
-$83.82 M-37.82%

December 31, 2023


Summary


Performance

FATE Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFATEbalance sheetmetrics:

Quarterly Total Liabilities

$132.64 M
+$809.00 K+0.61%

September 30, 2024


Summary


Performance

FATE Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFATEbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

FATE Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-37.8%-5.9%
3 y3 years-42.1%-13.2%
5 y5 years+162.2%+29.2%

FATE Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-43.2%at low-45.3%+0.6%
5 y5-year-43.2%+139.6%-49.7%+130.6%
alltimeall time-43.2%+2810.2%-49.7%+3289.8%

Fate Therapeutics Total Liabilities History

DateAnnualQuarterly
Sep 2024
-
$132.64 M(+0.6%)
Jun 2024
-
$131.84 M(-8.3%)
Mar 2024
-
$143.78 M(+4.3%)
Dec 2023
$137.80 M(-37.8%)
$137.80 M(-2.3%)
Sep 2023
-
$141.01 M(-4.1%)
Jun 2023
-
$147.00 M(-3.8%)
Mar 2023
-
$152.86 M(-31.0%)
Dec 2022
$221.62 M(-8.7%)
$221.62 M(-4.2%)
Sep 2022
-
$231.35 M(+2.1%)
Jun 2022
-
$226.58 M(+0.7%)
Mar 2022
-
$224.99 M(-7.3%)
Dec 2021
$242.62 M(+1.9%)
$242.62 M(-4.6%)
Sep 2021
-
$254.24 M(-3.5%)
Jun 2021
-
$263.60 M(+3.0%)
Mar 2021
-
$255.87 M(+7.5%)
Dec 2020
$238.01 M(+313.8%)
$238.01 M(+17.8%)
Sep 2020
-
$202.08 M(+12.6%)
Jun 2020
-
$179.48 M(+74.8%)
Mar 2020
-
$102.67 M(+78.5%)
Dec 2019
$57.52 M(+9.4%)
$57.52 M(-20.3%)
Sep 2019
-
$72.17 M(-0.3%)
Jun 2019
-
$72.35 M(-3.6%)
Mar 2019
-
$75.03 M(+42.7%)
Dec 2018
$52.56 M
$52.56 M(+14.2%)
DateAnnualQuarterly
Sep 2018
-
$46.02 M(+46.9%)
Jun 2018
-
$31.33 M(+10.2%)
Mar 2018
-
$28.43 M(+1.1%)
Dec 2017
$28.10 M(+28.4%)
$28.10 M(+4.4%)
Sep 2017
-
$26.93 M(+43.7%)
Jun 2017
-
$18.74 M(-12.7%)
Mar 2017
-
$21.47 M(-1.9%)
Dec 2016
$21.89 M(-26.8%)
$21.89 M(-8.5%)
Sep 2016
-
$23.92 M(-8.2%)
Jun 2016
-
$26.05 M(-6.9%)
Mar 2016
-
$27.98 M(-6.5%)
Dec 2015
$29.92 M(+31.0%)
$29.92 M(-4.7%)
Sep 2015
-
$31.41 M(-3.1%)
Jun 2015
-
$32.41 M(+39.5%)
Mar 2015
-
$23.24 M(+1.7%)
Dec 2014
$22.84 M(+382.4%)
$22.84 M(+70.0%)
Sep 2014
-
$13.43 M(+243.3%)
Jun 2014
-
$3.91 M(-12.5%)
Mar 2014
-
$4.47 M(-5.6%)
Dec 2013
$4.74 M(-92.6%)
$4.74 M(-94.7%)
Sep 2013
-
$89.44 M(+1314.6%)
Jun 2013
-
$6.32 M(-90.1%)
Dec 2012
$63.90 M(+9.2%)
$63.90 M
Dec 2011
$58.53 M
-

FAQ

  • What is Fate Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Fate Therapeutics?
  • What is Fate Therapeutics annual total liabilities year-on-year change?
  • What is Fate Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Fate Therapeutics?
  • What is Fate Therapeutics quarterly total liabilities year-on-year change?

What is Fate Therapeutics annual total liabilities?

The current annual total liabilities of FATE is $137.80 M

What is the all time high annual total liabilities for Fate Therapeutics?

Fate Therapeutics all-time high annual total liabilities is $242.62 M

What is Fate Therapeutics annual total liabilities year-on-year change?

Over the past year, FATE annual total liabilities has changed by -$83.82 M (-37.82%)

What is Fate Therapeutics quarterly total liabilities?

The current quarterly total liabilities of FATE is $132.64 M

What is the all time high quarterly total liabilities for Fate Therapeutics?

Fate Therapeutics all-time high quarterly total liabilities is $263.60 M

What is Fate Therapeutics quarterly total liabilities year-on-year change?

Over the past year, FATE quarterly total liabilities has changed by -$8.37 M (-5.93%)